Pure Biologics S.A. (WSE: PUR)

Pure Biologics Statistics

Total Valuation

Pure Biologics has a market cap or net worth of PLN 67.21 million. The enterprise value is 79.68 million.

Market Cap	67.21M
Enterprise Value	79.68M

Important Dates

The last earnings date was Friday, November 15, 2024.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

Pure Biologics has 3.69 million shares outstanding. The number of shares has decreased by -13.76% in one year.

Current Share Class	n/a
Shares Outstanding	3.69M
Shares Change (YoY)	-13.76%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	14.02%
Owned by Institutions (%)	8.29%
Float	2.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	147.94
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.00
EV / Sales	255.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.67

Current Ratio	0.67
Quick Ratio	0.59
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.52

Financial Efficiency

Return on equity (ROE) is -853.92% and return on invested capital (ROIC) is -61.43%.

Return on Equity (ROE)	-853.92%
Return on Assets (ROA)	-51.07%
Return on Capital (ROIC)	-61.43%
Revenue Per Employee	78,000
Profits Per Employee	-4.98M
Employee Count	51
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+70.50%
50-Day Moving Average	19.72
200-Day Moving Average	14.03
Relative Strength Index (RSI)	43.65
Average Volume (20 Days)	25,238

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pure Biologics had revenue of PLN 312,000 and -19.92 million in losses. Loss per share was -7.85.

Revenue	312,000
Gross Profit	-1.73M
Operating Income	-31.04M
Pretax Income	-34.35M
Net Income	-19.92M
EBITDA	-25.37M
EBIT	-31.04M
Loss Per Share	-7.85

Balance Sheet

The company has 1.28 million in cash and 13.75 million in debt, giving a net cash position of -12.47 million or -3.38 per share.

Cash & Cash Equivalents	1.28M
Total Debt	13.75M
Net Cash	-12.47M
Net Cash Per Share	-3.38
Equity (Book Value)	-4.98M
Book Value Per Share	-0.69
Working Capital	-5.24M

Cash Flow

Operating Cash Flow	-10.38M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-9,947.44%
Pretax Margin	-11,009.29%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pure Biologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	13.76%
Shareholder Yield	13.76%
Earnings Yield	-43.15%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a